NIH Study Links Gene Variants to Breast-Cancer Drug Side Effect
September 28, 2010 • National Institute of General Medical Sciences
Global Alliance for Pharmacogenomics Grows to 18 Projects
May 21, 2010 • National Institute of General Medical SciencesThe new projects focus on asthma, depression, leukemia, and bone fractures in women with breast cancer.
Global Alliance for Pharmacogenomics Adds Five New Projects
December 16, 2009 • National Institute of General Medical SciencesThe new projects, which focus on drugs for depression, HIV/AIDS, cardiovascular disease and cancer, bring to 15 the total number of projects in the Global Alliance for Pharmacogenomics.
Global Alliance for Pharmacogenomics Expands
November 10, 2008 • National Institute of General Medical Sciences
Five new collaborative projects will advance understanding of genetic factors that influence the safety and effectiveness of medicines.
Launching a Global Alliance for Pharmacogenomics
April 14, 2008 • National Institute of General Medical Sciences
U.S. and Japanese scientists partner to study genetic factors that influence the safety and effectiveness of medicines.